Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients

被引:3
作者
Coyne, Kathryn [1 ]
Silverman, Paula [2 ]
Liu, James H. [1 ]
机构
[1] Univ Hosp Cleveland, Univ Hosp MacDonald Womens Hosp, Dept Obstet & Gynecol, Med Ctr, Cleveland, OH 44106 USA
[2] Univ Hosp Seidman, Dept Med, Canc Ctr, Cleveland, OH USA
关键词
Elagolix; GnRH agonist; GnRH antagonist; Ovarian suppression; Premenopausal; PREMENOPAUSAL WOMEN; HUMAN SERUM; TESTOSTERONE; ESTRADIOL; THERAPY;
D O I
10.1016/j.clbc.2020.05.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E551 / E554
页数:4
相关论文
共 23 条
[1]   Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy [J].
Bellet, Meritxell ;
Gray, Kathryn P. ;
Francis, Prudence A. ;
Lang, Istvan ;
Ciruelos, Eva ;
Lluch, Ana ;
Angel Climent, Miguel ;
Catalan, Gustavo ;
Avella, Antoni ;
Bohn, Uriel ;
Gonzalez-Martin, Antonio ;
Ferrer, Roser ;
Catalan, Roberto ;
Azaro, Analia ;
Rajasekaran, Agnita ;
Morales, Josefa ;
Vazquez, Josep ;
Fleming, Gini F. ;
Price, Karen N. ;
Regan, Meredith M. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1584-U89
[2]   Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy [J].
Berntorp K. ;
Frid A. ;
Alm R. ;
Fredrikson G.N. ;
Sjöberg K. ;
Ohlsson B. .
BMC Research Notes, 6 (1)
[3]  
BHASIN S, 1994, J ANDROL, V15, P386
[4]  
BLUMENFELD Z, 1988, FERTIL STERIL, V50, P622
[5]   Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [J].
Burstein, Harold J. ;
Lacchetti, Christina ;
Anderson, Holly ;
Buchholz, Thomas A. ;
Davidson, Nancy E. ;
Gelmon, Karen E. ;
Giordano, Sharon H. ;
Hudis, Clifford A. ;
Solky, Alexander J. ;
Stearns, Vered ;
Winer, Eric P. ;
Griggs, Jennifer J. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1689-U250
[6]   Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial [J].
Castiglione-Gertsch, M ;
O'Neill, A ;
Price, KN ;
Goldhirsch, A ;
Coates, AS ;
Colleoni, M ;
Nasi, ML ;
Bonetti, M ;
Gelber, RD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24) :1833-1846
[7]   Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: Results from INT 0101 (E5188) [J].
Davidson, NE ;
O'Neill, AM ;
Vukov, AM ;
Osborne, CK ;
Martino, S ;
White, DR ;
Abeloff, MD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5973-5982
[8]   Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients [J].
de Ciantis, M. ;
Faure, C. ;
Heudel, P-E ;
Tredan, O. ;
Rousset-Jablonski, C. .
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (06) :261-264
[9]   Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial [J].
Dellapasqua, Silvia ;
Gray, Kathryn P. ;
Munzone, Elisabetta ;
Rubino, Daniela ;
Gianni, Lorenzo ;
Johansson, Harriet ;
Viale, Giuseppe ;
Ribi, Karin ;
Bernhard, Jurg ;
Kammler, Roswitha ;
Maibach, Rudolf ;
Rabaglio-Poretti, Manuela ;
Ruepp, Barbara ;
Di Leo, Angelo ;
Coates, Alan S. ;
Gelber, Richard D. ;
Regan, Meredith M. ;
Goldhirsch, Aron ;
Colleoni, Marco ;
Colleoni, M. ;
Di Leo, A. ;
Jerusalem, G. ;
Regan, M. ;
Viale, G. ;
Stahel, R. ;
Aebi, S. ;
Boyle, F. ;
Coates, A. ;
Colleoni, M. ;
Di Leo, A. ;
Gelber, R. ;
Goldhirsch, A. ;
Jerusalem, G. ;
Karlsson, P. ;
Kossler, I. ;
Regan, M. ;
Hiltbrunner, A. ;
Kuruvilla, Y. Chittazhathu Kurian ;
Fournarakou, S. ;
Fritzsche, L. ;
Gasca, A. ;
Kammler, R. ;
Maibach, R. ;
Pfister, R. ;
Rabaglio, M. ;
Weber, M. ;
Achille, G. ;
Celotto, D. ;
Regan, M. ;
Gelber, R. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) :386-+
[10]   Incomplete Estrogen Suppression With Gonadotropin- Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer [J].
Dowsett, Mitch ;
Lonning, Per E. ;
Davidson, Nancy E. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1580-U64